A Single NIR‐II Laser‐Triggered Self‐Enhancing Photo/Enzyme‐coupled Three‐in‐One Nanosystems for Breast Cancer Phototheranostics

Author:

Dai Rong12,Liu Qi23,Zhang Binyue1,Zhang Xin2,Gao Mengting1,Li Dongsheng1,Kang Weiwei2,Chen Lin2,Zhao Mingxin1,Zheng Ziliang1,Zhang Ruiping1ORCID

Affiliation:

1. Department of Radiology First hospital of Shanxi Medical University Taiyuan 030001 China

2. Institute of Medical Technology Shanxi Medical University Taiyuan 030001 China

3. Department of Radiology Shanxi cardiovascular hospital Taiyuan 030000 China

Abstract

AbstractMultifunctional phototheranostics, employing precise and non‐invasive techniques, is widely developed to enhance theranostic efficiency of breast cancer (BC), reduce side‐effects, and improve quality of life. Integrating all phototheranostic modalities into a single photosensitizer for highly effective BC treatment is particularly challenging due to the potential inefficiency and time consumption associated with repeated switching of multiple‐wavelength lasers. Herein, a novel single NIR‐II laser‐triggered three‐in‐one nanosystem(PdCu NY) is rationally designed, which enables dual‐modal (NIR‐II FL/NIR‐II PA) imaging‐guided self‐enhancing photothermal‐photodynamic therapy (PTT‐PDT) in NIR‐II window. The PdCu NY based on optimal Pd/Cu molar‐ratio(1:11) can be easily fabricated and large‐scale production for simultaneous PTT‐PDT against BC under a single 1064nm laser irradiation. Significantly, the PdCu NY acted as a promising photocatalyst for decomposition of H2O into O2 upon the same laser irradiation. In addition, the inherent catalase (CAT)‐like activity of PdCu NYs enables photo‐enzyme dual‐catalytic O2 supply to effectively alleviate hypoxia, achieving self‐enhanced PDT efficiency. These PTT‐PDT self‐enhanced nanosystems demonstrate precise lesion localization and complete tumor ablation using a single 1064nm laser source by “one‐laser, multi‐functions” strategy. More importantly, this study not only reports a three‐in‐one PdCu‐based phototheranostic agent, but also sheds light on the exploration of versatile biosafety nanosystems for clinical applications.

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Shanxi Province Science Foundation for Youths

National Ten Thousand Talent Program

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3